Perrigo Co. declined as much as 7.6 percent after it reported quarterly earnings that analyst Natali Gotlieb at IBI-Israel Brokerage & Investments ltd. said showed the maker of over-the-counter generics was facing more competition.
Perrigo declines as much as 7.6 percent after quarterly earnings